ConductScience.org, home
Papers
API referenceFor AI assistants

Paper393293

Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.

Vose BM and 2 others. Br J Cancer, 1979. Cited by 13 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases. Papers, record 393293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/393293

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Failure of leucocyte-adherence-inhibition assays to discriminate between benign and malignant breast diseases.
PubMed
Journal
Br J Cancer
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.62
iCite
Revised in PubMed
2019-05-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Vose BMB M
2Hughes RR
3Bazill GWG W

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast DiseasesMajor topic
Breast NeoplasmsMajor topic
Immunologic TechniquesMajor topic
Leukocyte Adherence Inhibition TestMajor topic
Antigens, Neoplasm
Diagnosis, Differential
Female
Humans

Source PubMed

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
177,883Leukocyte-adherence inhibition: a specific assay of cell-mediated immunity dependent on lymphokine-mediated collaboration between T lymphocytes.J Immunol1978https://conductscience.org/library/papers/77883PubMed
2228,691Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.Br J Cancer1979https://conductscience.org/library/papers/228691PubMed
3369,586A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay.Br J Cancer1978https://conductscience.org/library/papers/369586PubMed
4369,585The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition.Br J Cancer1978https://conductscience.org/library/papers/369585PubMed
5280,705Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.J Natl Cancer Inst1978https://conductscience.org/library/papers/280705PubMed
61,097,110Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.Cancer Res1975https://conductscience.org/library/papers/1097110PubMed
7743,487Leucocyte-migration-inhibition test in patients with colorectal cancer: clinicopathological correlations.Br J Cancer1978https://conductscience.org/library/papers/743487PubMed
8627,193[Immunodiagnostic aspects of breast cancer (author's transl)].Dtsch Med Wochenschr1978https://conductscience.org/library/papers/627193PubMed
9839,553Leukocyte migration inhibition in human pulmonary neoplasia.J Natl Cancer Inst1977https://conductscience.org/library/papers/839553PubMed
104,826,577Antigenic cross-reactivity between benign and malignant neoplasms of the human breast.J Natl Cancer Inst1974https://conductscience.org/library/papers/4826577PubMed
11761,231Cellular antitumor immune response in women with risk factors for breast cancer.Cancer Res1979https://conductscience.org/library/papers/761231PubMed

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
3,902,126Circulating anti-tumor and autoantibodies in breast carcinoma: relationship to stage and prognosis.Breast Cancer Res Treat1985https://conductscience.org/library/papers/3902126PubMed
3,782,265Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer.J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/3782265PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/393293

GET https://conductscience.org/api/papers/v1/393293/authors

API referenceFor AI assistants